Transcriptional regulation of human angiopoietin-2 by transcription factor Ets-1

Biochemical and Biophysical Research Communications

Volumn 316, Issue 1, 2004, Pages 52-58

  Hasegawa, Yasuhiro ^a,b   Abe, Mayumi ^a   Yamazaki, Tohru ^a   Niizeki, Osamu ^a   Shiiba, Kenichi ^b   Sasaki, Iwao ^b   Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiopoietin 2; Endothelial cell; Ets 1; Promoter; Transcriptional factor; VEGF

Indexed keywords

ANGIOPOIETIN 2; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERG 1; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETS 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BAY REGION BINDING SITE; CONTROLLED STUDY; DNA FLANKING REGION; ENDOTHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INDUCTION; TRANSCRIPTION REGULATION; TRANSLATION INITIATION; UMBILICAL VEIN;

ANGIOPOIETIN-2; ANIMALS; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RESPONSE ELEMENTS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 1542375454     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.019     Document Type: Article

References (33)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases? Nat. Med. 1:1995;27-31.
2. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 277:1997;48-50.
3. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., Yancopoulos G.D. Isolation of angiopoietin-1, a ligand for the TIE-2 receptor, by secretion-trap expression cloning. Cell. 87:1996;1161-1169.
4. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE-2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
5. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., Sato T.N., Yancopoulos G.D. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science. 277:1997;55-60.
6. ′ -kinase/Akt signal transduction pathway Oncogene. 19:2000;4549-4552.
7. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., Yancopoulos G.D., Wiegand S.J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science. 284:1999;1994-1998.
8. Asahara T., Chen D., Takahashi T., Fujikawa K., Kearney M., Magner M., Yancopoulos G.D., Isner J.M. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83:1998;233-240.
9. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell. Biol. 2:2001;827-837.
10. Wernert N., Raes M.B., Lassalle P., Dehouck M.P., Gosselin B., Vandenbunder B., Stehelin D. C-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140:1992;119-127.
11. Iwasaka C., Tanaka K., Abe M., Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J. Cell Physiol. 169:1996;522-531.
12. Tanaka K., Oda N., Iwasaka C., Abe M., Sato Y. Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J. Cell Physiol. 176:1998;235-244.
13. Tanaka K., Abe M., Sato Y. Roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the signal transduction of basic fibroblast growth factor in endothelial cells during angiogenesis. Jpn. J. Cancer Res. 90:1999;647-654.
14. Kanno S., Oda N., Abe M., Terai Y., Ito M., Shitara N., Tabayashi K., Shibuya M., Sato Y. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene. 19:2000;2138-2146.
15. Sato Y., Abe M., Tanaka K., Iwasaka C., Oda N., Kanno S., Oikawa M., Nakano T., Igarasi T. Signal transduction and transcriptional regulation of angiogenesis. Adv. Exp. Med. Biol. 476:2000;109-115.
16. Oda N., Abe M., Sato Y. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3. J. Cell Physiol. 178:1999;121-132.
17. Nakano T., Abe M., Tanaka K., Shineha R., Satomi S., Sato Y. Angiogenesis inhibition by transdominant mutant ets-1. J. Cell. Physiol. 184:2000;255-262.
18. Teruyama K., Abe M., Iwasaka-Yagi C., Nakano T., Takahashi S., Yamada S., Sato Y. Role of transcription factor Ets-1 in the apoptosis of human vascular endothelial cells. J. Cell Physiol. 188:2001;243-252.
19. Teruyama K., Abe M., Nakano T., Takahashi S., Yamada S., Sato Y. Neuropilin-1 is a downstream target of transcription factor Ets-1 in human umbilical vein endothelial cells. FEBS Lett. 504:2001;1-4.
20. Oikawa M., Abe M., Kurosawa H., Hida W., Shirato K., Sato Y. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia inducible factor-1. Biochem. Biophys. Res. Commun. 289:2001;39-43.
21. Mandriota S.J., Pepper M.S. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83:1998;852-859.
22. Abe M., Sato Y. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis. 4:2001;289-298.
23. Gale N.W., Thurston G., Hackett S.F., Renard R., Wang Q., McClain J., Martin C., Witte C., Witte M.H., Jackson D., Suri C., Campochiaro P.A., Wiegand S.J., Yancopoulos G.D. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell. 3:2002;411-423.
24. Stratmann A., Risau W., Plate K.H. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153:1998;1459-1466.
25. Jain R.K. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat. Med. 7:2001;987-989.
26. Hawighorst T., Skobe M., Streit M., Hong Y.K., Velasco P., Brown L.F., Riccardi L., Lange-Asschenfeldt B., Detmar M. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. Am. J. Pathol. 160:2002;1381-1392.
27. Zhang L., Yang N., Park J.W., Katsaros D., Fracchioli S., Cao G., O'Brien-Jenkins A., Randall T.C., Rubin S.C., Coukos G. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res. 63:2003;3403-3412.
28. Sato Y. Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct. Funct. 26:2001;19-24.
29. Maroulakou I.G., Papas T.S., Green J.E. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene. 9:1994;1551-1565.
30. Fujimoto J., Aoki I., Toyoki H., Khatun S., Tamaya T. Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers. Ann. Oncol. 13:2002;1598-1604.
31. Fujimoto J., Aoki I., Toyoki H., Khatun S., Tamaya T. Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers. Ann. Oncol. 13:2002;1605-1611.
32. Tokuhara K., Ogata Y., Nakagawa M., Shirouzu K. Ets-1 expression in vascular endothelial cells as an angiogenic and prognostic factor in colorectal carcinoma. Int. Surg. 88:2003;25-33.
33. Span P.N., Manders P., Heuvel J.J., Thomas C.M., Bosch R.R., Beex L.V., Sweep C.G. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene. 21:2002;8506-8509.